Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

Share Price is delayed by 15 minutes
Get Live Data
77.50    0.80 (1.04%)
Bid:
77.50
Ask:
77.70
Spread: 0.20 (0.258%)
Market Cap: £372.75m
CHRY Live PriceLast checked at - London Stock Exchange

Intraday Chrysalis Inves Share Chart

Portfolio Update

8 Mar 2021 07:09

RNS Number : 4578R
Chrysalis Investments Limited
08 March 2021
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in the Republic of Ireland), Canada, Australia, Japan or the Republic of South Africa.

 

 

8 March 2021

 

Chrysalis Investments Limited ("Chrysalis" or the "Company")

 

Portfolio Update

 

As announced on 26 February 2021, the Company's net asset value ("NAV") per ordinary share was 180.75 pence as of 31 December 2020. The Company subsequently announced on 1 March 2021 an estimated revised valuation of the Company's investment in Klarna Holding AB, due to its funding round, would result in a gross increase in the NAV per ordinary share of approximately 32p (based on Swedish Krona foreign exchange rates as of 26 February 2021) as compared to the Company's last reported NAV per ordinary share.

The Company notes Starling Bank's announcement today of the completion of a major funding round - conducted at a post new-money valuation of £1.3 billion - which represents a material uplift on the Company's carrying value of that asset. It is anticipated that this will lead to a gross NAV per share increase of approximately 6p compared to the Company's last reported NAV per share (calculated on the basis that the achieved valuation on the funding round is applied to revalue the Company's holding of the asset).

The round, which was led by Fidelity Investments and included The Qatar Investment Authority, RailPen Investments and Millennium Management, has raised £272 million of capital to allow Starling to continue its rapid expansion in the UK, as well as launching Starling into Europe and offer M&A flexibility. The funding round is subject to approval by the regulatory authorities.

Starling's recent growth has been exceptional. In February 2020, the bank had approximately £1 billion of customer deposits; as of today, customer deposits are greater than £5.4 billion. In addition, lending has exceeded £2 billion and the bank had achieved its fourth consecutive month of profitability. As of January 2021, run rate net profit was in excess of £1.5 million per month with an annualised run-rate revenue of approximately £145m - an increase of over 400% year on year. Growth continues to be strong with a new customer being added every 39 seconds.

The Company has not participated in the round. However, the Company's Investment Adviser has structured an option, but not an obligation, to allow the Company to participate should it wish to do so in the future. As announced by the Company on 17 February 2021, the Investment Adviser has identified circa £250 million of potential follow-on opportunities for the coming months and this option forms part of that.

Shareholders should note that the gross NAV per ordinary share increases referenced in this announcement and the Company's announcement on 1 March 2021 do not include the fees that may accrue as a result of the changes to this valuation, or any other portfolio company revaluations and associated foreign exchange movements that may be included when the Company next calculates its NAV per ordinary share as at 31 March 2021.

Richard Watts and Nick Williamson (co-Portfolio Managers) comment:

"Starling has shown extraordinary agility to react to the challenging conditions over the last 12 months, as demonstrated by its explosive growth in deposits and profitability. This was facilitated by significant commitment of capital by its shareholders, including Chrysalis Investments, over the course of 2020, which allowed a rapid expansion of its activities.

The endorsement of its valuation and validation of its operating model by new investors underlines the recent progress made. The potential for further profitable growth is highlighted by the fact that Starling managed to drive last year's revenue performance with monthly operating costs staying broadly flat over that period. We believe the expansion of the shareholder base gives Starling a very strong footing from which to continue its growth trajectory, and given its operational gearing dynamics, we remain highly optimistic over its financial prospects.

We believe the likelihood of further value creation for the Company's investors is significant from this asset, and as such, we have negotiated the option for Chrysalis Investments to participate in this round in the coming months."

 

-ENDS-

 

 

For further information, please contact:

 

Media:

Montfort Communications

Charlotte McMullen/ Toto Reissland- Burgh art/ Miles McKenzie

 

 

 

 

+44 (0) 20 3770 7920

chrysalis@montfort.london

 

Jupiter Asset Management:

Magnus Spence

 

+44 (0) 20 3817 1325

Liberum:

Gillian Martin / Owen Matthews

 

+44 (0) 20 3100 2000

Numis:

Nathan Brown/ Matt Goss

 

+44 (0) 20 7260 1000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

+44 (0) 1481 749364

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk

The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFIFIDVTITIIL
Date   Source Headline
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
20th Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:01 amRNSAnnual Report and Audited Financial Statements
10th Jan 20257:00 amRNSHolding(s) in Company
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:01 amRNSUpdate on claim against Revolution Beauty Group
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:01 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20241:14 pmRNSDisposal and Portfolio Update
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
4th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 202410:58 amRNSHolding(s) in Company
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
21st Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.